Bioventus Q2 Adj. EPS $0.14 Beats $0.03 Estimate, Sales $137.10M Beat $128.90M Estimate
Portfolio Pulse from Benzinga Newsdesk
Bioventus (NASDAQ:BVS) reported Q2 earnings of $0.14 per share, beating the analyst consensus estimate of $0.03 by 366.67%. This is a 40% increase from the same period last year. The company also reported quarterly sales of $137.10 million, beating the analyst consensus estimate of $128.90 million by 6.36%, but this is a 2.30% decrease from the same period last year.
August 08, 2023 | 11:32 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bioventus reported strong Q2 earnings, beating estimates significantly. However, sales decreased slightly compared to the same period last year.
Bioventus reported a significant beat on earnings estimates, which is likely to be viewed positively by the market. However, the slight decrease in sales YoY might temper this positive impact somewhat.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100